Compare Globus Medical Inc. Class A Common Stock (GMED) vs Palantir Technologies Inc (PLTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Palantir Technologies Inc — how do they compare? Globus Medical Inc. Class A Common Stock trades at $78.05 (market cap $10.25B), while Palantir Technologies Inc trades at $196.85 (market cap $482.94B). The key difference: Palantir Technologies Inc is far larger — about 47.1× Globus Medical Inc. Class A Common Stock's market cap, and Palantir Technologies Inc is trading nearer its 52-week high, Globus Medical Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Palantir Technologies Inc for 79 Days on average.
| GMED | PLTR | |
|---|---|---|
Market Cap | $10.25B | $482.94B |
Volume | 1,059,528 | 24,103,301 |
Sector | Health | Technology |
52-Week High | $96.82 | $209.05 |
52-Week Low | $58.33 | $107.27 |
Typical Hold Time | 0 Days | 79 Days |
Enterprise Value | $9.76B | $473.74B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Palantir (PLTR) trades at $208.64, down slightly (-0.17%) on the day, maintaining a strong bullish technical trend near its pivot point of $209. The company demonstrates exceptional fundamental strength with 2025 revenue reaching $4.48 billion and net income surging to $1.63 billion, representing a 36.3% margin. Recent partnership announcements with Armada for sovereign AI infrastructure highlight ongoing business momentum.
While valuation ratios remain elevated (P/E 171.77, P/S 83.94), Palantir's consistent earnings beats and projected revenue growth to $6.2 billion in 2026 support the bullish case. Primary risks include premium valuation sensitivity and competitive pressures in the AI software space. Analyst consensus leans bullish with 54% buy ratings and a $195.86 price target.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Palantir Technologies Inc
Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Palantir expanded into various commercial markets with its Foundry software platform in 2016 with the intent of becoming the data operating system for companies and industries. The Denver company had 125 customers as of its initial public offering and roughly splits its revenue between commercial and government customers.
Read more on PLTR →
